| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/DOM.13008 |
| P698 | PubMed publication ID | 28880480 |
| P50 | author | Pegah Poursharifi | Q51318805 |
| Sri Ramachandra Murthy Madiraju | Q88929302 | ||
| P2093 | author name string | Marc Prentki | |
| P2860 | cites work | Biochemical and pharmacological characterization of human α/β-hydrolase domain containing 6 (ABHD6) and 12 (ABHD12) | Q24298516 |
| Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain | Q24299523 | ||
| Brain monoglyceride lipase participating in endocannabinoid inactivation | Q24533828 | ||
| The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors | Q24602845 | ||
| The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors | Q24617322 | ||
| Activity-based proteomics of enzyme superfamilies: serine hydrolases as a case study | Q24634117 | ||
| A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol | Q24649418 | ||
| Lack of selectivity of URB602 for 2-oleoylglycerol compared to anandamide hydrolysis in vitro | Q24673383 | ||
| A clinical review of GLP-1 receptor agonists: efficacy and safety in diabetes and beyond | Q26799389 | ||
| The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders | Q27009022 | ||
| Intestinal triacylglycerol synthesis in fat absorption and systemic energy metabolism | Q27023275 | ||
| Cancer statistics, 2015 | Q27860576 | ||
| Impaired gene and protein expression of exocytotic soluble N-ethylmaleimide attachment protein receptor complex proteins in pancreatic islets of type 2 diabetic patients | Q27863911 | ||
| Glycerolipid metabolism and signaling in health and disease | Q27865220 | ||
| Dual-Acting Compounds Targeting Endocannabinoid and Endovanilloid Systems-A Novel Treatment Option for Chronic Pain Management | Q28067493 | ||
| Brown and Beige Fat: Molecular Parts of a Thermogenic Machine | Q28082723 | ||
| Lipid phosphate phosphatases and their roles in mammalian physiology and pathology | Q28088430 | ||
| α/β-Hydrolase domain-6 and saturated long chain monoacylglycerol regulate insulin secretion promoted by both fuel and non-fuel stimuli. | Q41769019 | ||
| Studies on the substrate and stereo/regioselectivity of adipose triglyceride lipase, hormone-sensitive lipase, and diacylglycerol-O-acyltransferases | Q41818160 | ||
| Simplified assays of lipolysis enzymes for drug discovery and specificity assessment of known inhibitors. | Q41906728 | ||
| Porcupine Controls Hippocampal AMPAR Levels, Composition, and Synaptic Transmission | Q41942876 | ||
| Blockade of monoacylglycerol lipase inhibits oligodendrocyte excitotoxicity and prevents demyelination in vivo. | Q42464099 | ||
| Genetic deletion of monoacylglycerol lipase alters endocannabinoid-mediated retrograde synaptic depression in the cerebellum | Q42494226 | ||
| Targeting triglyceride/fatty acid cycling in β-cells as a therapy for augmenting glucose-stimulated insulin secretion | Q42794164 | ||
| α/β-Hydrolase Domain 6 Deletion Induces Adipose Browning and Prevents Obesity and Type 2 Diabetes. | Q42812581 | ||
| Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease | Q43162071 | ||
| In vitro stereoselective hydrolysis of diacylglycerols by hormone-sensitive lipase. | Q43267747 | ||
| Isolation of lysophosphatidic acid phosphatase from developing peanut cotyledons. | Q43916209 | ||
| Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide | Q44267931 | ||
| 2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces accelerated production of chemokines in HL-60 cells | Q44872391 | ||
| Intramolecular occlusion of the diacylglycerol-binding site in the C1 domain of munc13-1. | Q45235934 | ||
| Fatty acid amide hydrolase but not monoacyl glycerol lipase controls cell death induced by the endocannabinoid 2-arachidonoyl glycerol in hepatic cell populations | Q45282573 | ||
| PXK locus in systemic lupus erythematosus: fine mapping and functional analysis reveals novel susceptibility gene ABHD6. | Q46023783 | ||
| A functional proteomic strategy to discover inhibitors for uncharacterized hydrolases | Q46044614 | ||
| A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like Peptide-1 and glucose-dependent insulinotropic Peptide release | Q46665845 | ||
| Evaluation of the 'side door' in carboxylesterase-mediated catalysis and inhibition | Q46829757 | ||
| Expression and function of monoacylglycerol lipase in mouse β-cells and human islets of Langerhans | Q47445877 | ||
| Munc13-1 deficiency reduces insulin secretion and causes abnormal glucose tolerance | Q48563863 | ||
| Discovery of glycine sulfonamides as dual inhibitors of sn-1-diacylglycerol lipase α and α/β-hydrolase domain 6. | Q48681871 | ||
| Activation of CB2 receptor is required for the therapeutic effect of ABHD6 inhibition in experimental autoimmune encephalomyelitis. | Q50953458 | ||
| Enzymes catalyzing the hydrolysis of long-chain monoacyglycerols in rat adipose tissue | Q51664193 | ||
| Stereoselective hydrolysis of triglycerides by animal and microbial lipases | Q56625602 | ||
| Intestinal Monoacylglycerol Metabolism | Q57843934 | ||
| Glucagon-like peptide-1 promotes DNA synthesis, activates phosphatidylinositol 3-kinase and increases transcription factor pancreatic and duodenal homeobox gene 1 (PDX-1) DNA binding activity in beta (INS-1)-cells | Q58088431 | ||
| From Phytocannabinoids to Cannabinoid Receptors and Endocannabinoids: Pleiotropic Physiological and Pathological Roles Through Complex Pharmacology | Q38821074 | ||
| Role of lipids in the metabolism and activation of immune cells | Q38899326 | ||
| Transient Receptor Potential Channels in neuropathic pain | Q39005452 | ||
| High expression of the evolutionarily conserved alpha/beta hydrolase domain containing 6 (ABHD6) in Ewing tumors | Q39793314 | ||
| Monoacylglycerols activate capsaicin receptor, TRPV1. | Q39982192 | ||
| Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia | Q40282032 | ||
| α/β Hydrolase Domain-containing 6 (ABHD6) Degrades the Late Endosomal/Lysosomal Lipid Bis(monoacylglycero)phosphate | Q40404245 | ||
| α/β-Hydrolase Domain 6 in the Ventromedial Hypothalamus Controls Energy Metabolism Flexibility. | Q40514195 | ||
| Monoglyceride lipase-like enzymatic activity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes. | Q40525710 | ||
| Effects of cannabinoids on LPS-stimulated inflammatory mediator release from macrophages: involvement of eicosanoids. | Q40809261 | ||
| 2-Arachidonylglycerol, an endogenous cannabinoid, inhibits tumor necrosis factor-alpha production in murine macrophages, and in mice | Q40852080 | ||
| Adenosine activates brown adipose tissue and recruits beige adipocytes via A2A receptors | Q41700452 | ||
| Unconventional endocannabinoid signaling governs sperm activation via the sex hormone progesterone | Q28118748 | ||
| 2-Oleoyl glycerol is a GPR119 agonist and signals GLP-1 release in humans | Q28243838 | ||
| cDNA cloning, tissue distribution, and identification of the catalytic triad of monoglyceride lipase. Evolutionary relationship to esterases, lysophospholipases, and haloperoxidases | Q28252158 | ||
| 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain | Q28290395 | ||
| Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors | Q28292914 | ||
| Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents | Q28300398 | ||
| The serine hydrolase ABHD6 Is a critical regulator of the metabolic syndrome | Q28504726 | ||
| ABHD12 controls brain lysophosphatidylserine pathways that are deregulated in a murine model of the neurodegenerative disease PHARC | Q28509608 | ||
| Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor | Q28509942 | ||
| Adipose triglyceride lipase and hormone-sensitive lipase are the major enzymes in adipose tissue triacylglycerol catabolism | Q28512146 | ||
| Monoacylglycerols activate TRPV1--a link between phospholipase C and TRPV1 | Q28535638 | ||
| Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system | Q28590486 | ||
| The hereditary spastic paraplegia-related enzyme DDHD2 is a principal brain triglyceride lipase | Q28591427 | ||
| The cloned capsaicin receptor integrates multiple pain-producing stimuli | Q29547511 | ||
| PPARs and the complex journey to obesity | Q29619271 | ||
| Adipose triglyceride lipase (ATGL) and hormone-sensitive lipase (HSL) deficiencies affect expression of lipolytic activities in mouse adipose tissues | Q30529628 | ||
| Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2. | Q30606134 | ||
| Inactivation of lipid glyceryl ester metabolism in human THP1 monocytes/macrophages by activated organophosphorus insecticides: role of carboxylesterases 1 and 2 | Q30981876 | ||
| Fat poetry: a kingdom for PPAR gamma | Q33437489 | ||
| Superfamily-wide portrait of serine hydrolase inhibition achieved by library-versus-library screening | Q33749260 | ||
| Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis | Q33914549 | ||
| Demonstration of an intestinal monoglyceride lipase: an enzyme with a possible role in the intracellular completion of fat digestion | Q33943103 | ||
| ABHD6 blockade exerts antiepileptic activity in PTZ-induced seizures and in spontaneous seizures in R6/2 mice | Q34060224 | ||
| 2-Arachidonoylglycerol and the cannabinoid receptors | Q34098975 | ||
| Biosynthesis and degradation of the endocannabinoid 2-arachidonoylglycerol | Q34165188 | ||
| Prostaglandins and inflammation | Q34179727 | ||
| The membrane fusion enigma: SNAREs, Sec1/Munc18 proteins, and their accomplices--guilty as charged? | Q34305507 | ||
| Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase | Q34369246 | ||
| Brown and beige fat: development, function and therapeutic potential | Q34375850 | ||
| An unannotated alpha/beta hydrolase superfamily member, ABHD6 differentially expressed among cancer cell lines | Q34764248 | ||
| Physiological roles of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand | Q34968661 | ||
| Monoglyceride lipase deficiency in mice impairs lipolysis and attenuates diet-induced insulin resistance. | Q34978868 | ||
| Immunomodulatory lysophosphatidylserines are regulated by ABHD16A and ABHD12 interplay | Q34995628 | ||
| Cellular target genes of Epstein-Barr virus nuclear antigen 2. | Q35101342 | ||
| Monoacylglycerol lipase exerts dual control over endocannabinoid and fatty acid pathways to support prostate cancer | Q35146525 | ||
| The metabolic serine hydrolases and their functions in mammalian physiology and disease | Q35333042 | ||
| The digestion of dietary triacylglycerols. | Q35599797 | ||
| Peroxisome proliferator-activated receptor α (PPARα) induces PPARγ coactivator 1α (PGC-1α) gene expression and contributes to thermogenic activation of brown fat: involvement of PRDM16. | Q35604665 | ||
| Optimization of 1,2,5-thiadiazole carbamates as potent and selective ABHD6 inhibitors. | Q35753542 | ||
| Mechanisms of lysophosphatidic acid production | Q35844014 | ||
| G protein-coupled receptors and insulin secretion: 119 and counting | Q35867521 | ||
| Evidence for regulated monoacylglycerol acyltransferase expression and activity in human liver. | Q35897072 | ||
| Inhibition of Monoacylglycerol Lipase Activity Decreases Glucose-Stimulated Insulin Secretion in INS-1 (832/13) Cells and Rat Islets | Q35920878 | ||
| Obesity, metabolic syndrome, and type 2 diabetes: emerging epidemics and their cardiovascular implications | Q35926379 | ||
| Characterization of the Mouse and Human Monoacylglycerol O-Acyltransferase 1 (Mogat1) Promoter in Human Kidney Proximal Tubule and Rat Liver Cells | Q36128458 | ||
| An in vivo multiplexed small-molecule screening platform | Q36129729 | ||
| DAGLβ inhibition perturbs a lipid network involved in macrophage inflammatory responses | Q36443943 | ||
| Mammalian alpha beta hydrolase domain (ABHD) proteins: Lipid metabolizing enzymes at the interface of cell signaling and energy metabolism | Q36612260 | ||
| Biochemistry and pathophysiology of intravascular and intracellular lipolysis | Q36708030 | ||
| Selective inhibition of alpha/beta-hydrolase domain 6 attenuates neurodegeneration, alleviates blood brain barrier breakdown, and improves functional recovery in a mouse model of traumatic brain injury | Q36795890 | ||
| α/β-Hydrolase domain-containing 6 (ABHD6) negatively regulates the surface delivery and synaptic function of AMPA receptors | Q36905084 | ||
| Diverse roles of 2-arachidonoylglycerol in invasion of prostate carcinoma cells: Location, hydrolysis and 12-lipoxygenase metabolism. | Q36932469 | ||
| Implication of the anti-inflammatory bioactive lipid prostaglandin D2-glycerol ester in the control of macrophage activation and inflammation by ABHD6. | Q37256080 | ||
| Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation | Q37286185 | ||
| Glycerol-3-phosphate acyltransferases: rate limiting enzymes of triacylglycerol biosynthesis | Q37332722 | ||
| The Role of PPARs in the Endothelium: Implications for Cancer Therapy | Q37337997 | ||
| What we talk about when we talk about fat. | Q37601812 | ||
| Discovery and optimization of piperidyl-1,2,3-triazole ureas as potent, selective, and in vivo-active inhibitors of α/β-hydrolase domain containing 6 (ABHD6) | Q37704738 | ||
| A review on the monoacylglycerol lipase: at the interface between fat and endocannabinoid signalling. | Q37758870 | ||
| Glycerolipid/free fatty acid cycle and islet β-cell function in health, obesity and diabetes | Q37959707 | ||
| GPR119 as a fat sensor | Q38007638 | ||
| Metabolic signaling in fuel-induced insulin secretion | Q38116234 | ||
| Adipose tissue browning and metabolic health | Q38154504 | ||
| Open questions in lipid droplet biology. | Q38163178 | ||
| Brown fat fuel utilization and thermogenesis | Q38175686 | ||
| FAT FLUX: enzymes, regulators, and pathophysiology of intracellular lipolysis | Q38325443 | ||
| Systemic transcriptome analysis of hepatocellular carcinoma | Q38755671 | ||
| Oral 2-oleyl glyceryl ether improves glucose tolerance in mice through the GPR119 receptor. | Q38764638 | ||
| P304 | page(s) | 76-89 | |
| P577 | publication date | 2017-09-01 | |
| P1433 | published in | Diabetes, Obesity and Metabolism | Q5270109 |
| P1476 | title | Monoacylglycerol signalling and ABHD6 in health and disease | |
| P478 | volume | 19 Suppl 1 |
| Q92210185 | A Preliminary Investigation towards the Risk Stratification of Allogeneic Stem Cell Recipients with Respect to the Potential for Development of GVHD via Their Pre-Transplant Plasma Lipid and Metabolic Signature |
| Q90191256 | Druggable targets of the endocannabinoid system: Implications for the treatment of HIV-associated neurocognitive disorder |
| Q90112578 | Enhanced monoacylglycerol lipolysis by ABHD6 promotes NSCLC pathogenesis |
| Q90031556 | Monoacylglycerol Lipase Inhibition Protects From Liver Injury in Mouse Models of Sclerosing Cholangitis |
| Q87859320 | Non-endocannabinoid N-acylethanolamines and 2-monoacylglycerols in the intestine |
| Q91814182 | SWATH Differential Abundance Proteomics and Cellular Assays Show In Vitro Anticancer Activity of Arachidonic Acid- and Docosahexaenoic Acid-Based Monoacylglycerols in HT-29 Colorectal Cancer Cells |
| Q55441249 | Sequence analysis and structure prediction of ABHD16A and the roles of the ABHD family members in human disease. |
| Q90823333 | The role of metabolic lipases in the pathogenesis and management of liver disease |
Search more.